LB Pharmaceuticals, Inc. (LBRX)
39.42
+0.19
(+0.48%)
USD |
NASDAQ |
Oct 22, 16:00
39.77
+0.35
(+0.89%)
After-Hours: 20:00
LB Pharmaceuticals Price to Book Value : 3.402 for Oct. 22, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 22, 2026 | 3.402 |
| October 21, 2026 | 3.386 |
| October 20, 2026 | 3.538 |
| October 19, 2026 | 3.349 |
| October 16, 2026 | 3.171 |
| October 15, 2026 | 3.166 |
| October 14, 2026 | 2.934 |
| October 13, 2026 | 3.002 |
| October 12, 2026 | 3.101 |
| October 09, 2026 | 3.212 |
| October 08, 2026 | 2.987 |
| October 07, 2026 | 2.948 |
| October 06, 2026 | 2.957 |
| October 05, 2026 | 2.988 |
| October 02, 2026 | 3.192 |
| October 01, 2026 | 3.217 |
| September 30, 2026 | 3.312 |
| September 29, 2026 | 3.217 |
| September 28, 2026 | 3.270 |
| September 25, 2026 | 3.222 |
| September 24, 2026 | 3.262 |
| September 23, 2026 | 3.382 |
| September 22, 2026 | 3.684 |
| September 21, 2026 | 3.71 |
| September 18, 2026 | 3.665 |
| Date | Value |
|---|---|
| September 17, 2026 | 3.637 |
| September 16, 2026 | 3.674 |
| September 15, 2026 | 3.714 |
| September 14, 2026 | 3.870 |
| September 11, 2026 | 3.852 |
| September 10, 2026 | 3.991 |
| September 09, 2026 | 4.114 |
| September 08, 2026 | 4.262 |
| September 04, 2026 | 4.258 |
| September 03, 2026 | 4.101 |
| September 02, 2026 | 4.270 |
| September 01, 2026 | 4.065 |
| August 31, 2026 | 4.078 |
| August 28, 2026 | 4.119 |
| August 27, 2026 | 4.133 |
| August 26, 2026 | 4.157 |
| August 25, 2026 | 4.211 |
| August 24, 2026 | 4.160 |
| August 21, 2026 | 4.110 |
| August 20, 2026 | 4.076 |
| August 19, 2026 | 4.224 |
| August 18, 2026 | 4.209 |
| August 17, 2026 | 3.990 |
| August 14, 2026 | 4.123 |
| August 13, 2026 | 3.820 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Ligand Pharmaceuticals, Inc. | 6.338 |
| ANI Pharmaceuticals, Inc. | 2.837 |
| Corcept Therapeutics, Inc. | 16.44 |
| Veru, Inc. | 1.376 |
| Johnson & Johnson | 7.901 |
Price to Book Value Related Metrics
| PEG Ratio | -0.1001 |
| Price | 39.42 |
| Earnings Yield | -7.56% |
| Market Cap | 1.131B |
| PEGY Ratio | -0.1001 |